Published in Jpn J Ophthalmol on July 27, 2008
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist (2011) 2.05
Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol (2012) 1.71
Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm (2009) 1.14
Primary intraocular lymphoma. Arch Pathol Lab Med (2009) 1.13
A case of primary intraocular lymphoma treated by intravitreal methotrexate. Korean J Ophthalmol (2009) 0.89
IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefes Arch Clin Exp Ophthalmol (2012) 0.85
The future of primary intraocular lymphoma (retinal lymphoma). Ocul Immunol Inflamm (2009) 0.84
[Diagnostics and treatment of primary vitreoretinal lymphoma]. Ophthalmologe (2015) 0.80
Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma. PLoS One (2013) 0.78
Optical coherence tomography manifestations of primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Cancer Sci (2016) 0.75
Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys (1992) 2.84
Intraocular lymphoma: update on diagnosis and management. Cancer Control (2004) 1.62
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol (1995) 1.43
Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology (2002) 1.42
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol (1999) 1.21
Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye (Lond) (2003) 1.17
High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15
CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev (2006) 1.15
Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am (2005) 1.08
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol (1997) 1.04
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma. Cancer (2002) 0.86
Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol (1999) 0.84
Management of primary intraocular lymphoma. Curr Oncol Rep (2005) 0.78
Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med (2004) 4.91
Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. Nat Neurosci (2003) 3.08
Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol (2002) 2.59
Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci (2008) 2.35
Math3 and NeuroD regulate amacrine cell fate specification in the retina. Development (2002) 2.07
Scleral imbrication combined with vitrectomy and gas tamponade for refractory macular hole retinal detachment associated with high myopia. Retina (2014) 2.06
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents. Int J Urol (2012) 2.05
Bimonthly injections of ranibizumab for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2014) 2.04
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology (2008) 1.96
Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology (2009) 1.96
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology (2007) 1.81
A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology (2009) 1.80
Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation (2004) 1.76
Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2009) 1.75
Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol (2008) 1.59
Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature (2003) 1.55
Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol (2008) 1.55
Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol (2007) 1.53
Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett (2004) 1.51
Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years. Int J Urol (2009) 1.48
Chandelier retroillumination-assisted torsional oscillation for cataract surgery in patients with severe corneal opacity. J Cataract Refract Surg (2007) 1.46
Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina (2004) 1.44
Potent retinal arteriolar traction as a possible cause of myopic foveoschisis. Am J Ophthalmol (2005) 1.43
Histological evaluation of mechanical epithelial separation in epithelial laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.40
PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes (2002) 1.39
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology (2009) 1.37
Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J (2005) 1.37
Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol (2006) 1.34
Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis (2007) 1.33
N-Cadherin is expressed by putative stem/progenitor cells and melanocytes in the human limbal epithelial stem cell niche. Stem Cells (2006) 1.33
Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells (2005) 1.33
Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol (2003) 1.30
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology (2008) 1.28
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2012) 1.28
Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.27
Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology (2013) 1.25
Tractional internal limiting membrane detachment in highly myopic eyes. Am J Ophthalmol (2006) 1.25
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) (2009) 1.25
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology (2008) 1.23
Wavefront aberrations measured with Hartmann-Shack sensor in patients with keratoconus. Ophthalmology (2002) 1.22
Higher-order aberrations due to the posterior corneal surface in patients with keratoconus. Invest Ophthalmol Vis Sci (2008) 1.21
Magnitude and orientation of Zernike terms in patients with keratoconus. Invest Ophthalmol Vis Sci (2007) 1.20
Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol (2009) 1.19
iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis (2009) 1.19
Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol (2008) 1.18
Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.17
Bacteriologic profile of the conjunctiva in the patients with dry eye. Am J Ophthalmol (2008) 1.17
Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol (2004) 1.17
Topical nepafenac inhibits ocular neovascularization. Invest Ophthalmol Vis Sci (2003) 1.16
Effects of prehospital epinephrine during out-of-hospital cardiac arrest with initial non-shockable rhythm: an observational cohort study. Crit Care (2013) 1.16
Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci (2004) 1.16
Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol (2006) 1.15
Wide-angle viewing lens for vitrectomy. Am J Ophthalmol (2004) 1.14
Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Invest Ophthalmol Vis Sci (2012) 1.13
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol (2004) 1.13
Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci (2008) 1.13
Evaluation of phosphenes elicited by extraocular stimulation in normals and by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Retinal vascular microfolds in highly myopic eyes. Am J Ophthalmol (2005) 1.11
Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci (2008) 1.11
Changes of ocular aberration with accommodation. Am J Ophthalmol (2002) 1.11
Age-related changes in ocular and corneal aberrations. Am J Ophthalmol (2004) 1.10
Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci (2007) 1.10
Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci (2005) 1.10
Effect of tear film break-up on higher-order aberrations measured with wavefront sensor. Am J Ophthalmol (2002) 1.10
Age at onset curves of retinitis pigmentosa. Arch Ophthalmol (2008) 1.09
Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol (2004) 1.08
Dkk3-Cre BAC transgenic mouse line: a tool for highly efficient gene deletion in retinal progenitor cells. Genesis (2007) 1.08
Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus. Ophthalmology (2009) 1.08
Intramolecular interaction of SUR2 subtypes for intracellular ADP-Induced differential control of K(ATP) channels. Circ Res (2002) 1.08
One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2009) 1.07
Serial measurements of higher-order aberrations after blinking in normal subjects. Invest Ophthalmol Vis Sci (2006) 1.07
Self-retaining 27-gauge transconjunctival chandelier endoillumination for panoramic viewing during vitreous surgery. Am J Ophthalmol (2006) 1.05
Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res (2010) 1.05
Extranodal Rosai-Dorfman disease: a solitary lesion with soft tissue reaction. Radiat Med (2005) 1.05
Guidelines for PDT in Japan. Ophthalmology (2008) 1.05
Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy. Int Ophthalmol (2009) 1.04
p57Kip2 is expressed in quiescent mouse bone marrow side population cells. Biochem Biophys Res Commun (2005) 1.04
Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol (2008) 1.03
Early macular holes with retinoschisis in highly myopic eyes. Am J Ophthalmol (2003) 1.03
Macular autofluorescence in eyes with cystoid macula edema, detected with 488 nm-excitation but not with 580 nm-excitation. Graefes Arch Clin Exp Ophthalmol (2009) 1.03
Ocular surface reconstruction using autologous rabbit oral mucosal epithelial sheets fabricated ex vivo on a temperature-responsive culture surface. Invest Ophthalmol Vis Sci (2005) 1.03
Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci (2010) 1.02
F-18 FDG PET/CT imaging of low-grade mucoepidermoid carcinoma of the bronchus. Ann Nucl Med (2007) 1.02
Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase. Proc Natl Acad Sci U S A (2006) 1.02
Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases. Ann Acad Med Singapore (2006) 1.01
Photodynamic therapy in macular diseases of asian populations: when East meets West. Jpn J Ophthalmol (2006) 1.01
Ultrasound biomicroscopic examination of acute hydrops in patients with keratoconus. Am J Ophthalmol (2006) 1.01
Tautomerism of histidine 64 associated with proton transfer in catalysis of carbonic anhydrase. J Biol Chem (2007) 1.01
Structural characterization of bioengineered human corneal endothelial cell sheets fabricated on temperature-responsive culture dishes. Biomaterials (2005) 1.01
CT and MRI features of low-grade fibromyxoid sarcoma in the shoulder of a pediatric patient. Radiat Med (2006) 1.00
Spectral-domain optical coherence tomographic findings in myopic foveoschisis. Retina (2010) 1.00
Anterior segment optical coherence tomography findings of presumed intraocular tuberculosis. Cutan Ocul Toxicol (2010) 1.00
Foveal anatomical status and surgical results in vitrectomy for myopic foveoschisis. Jpn J Ophthalmol (2008) 1.00
Electrophysiological studies of the feasibility of suprachoroidal-transretinal stimulation for artificial vision in normal and RCS rats. Invest Ophthalmol Vis Sci (2004) 1.00
Light scattering and optical aberrations as objective parameters to predict visual deterioration in eyes with cataracts. J Cataract Refract Surg (2004) 0.99
A spectrum of clinical manifestations of gelatinous drop-like corneal dystrophy in japan. Am J Ophthalmol (2004) 0.99